Hrad17, a Structural Homolog of the Schizosaccharomyces Pombe RAD17 Cell Cycle Checkpoint Gene, Stimulates P53 Accumulation

Total Page:16

File Type:pdf, Size:1020Kb

Hrad17, a Structural Homolog of the Schizosaccharomyces Pombe RAD17 Cell Cycle Checkpoint Gene, Stimulates P53 Accumulation Oncogene (1999) 18, 1689 ± 1699 ã 1999 Stockton Press All rights reserved 0950 ± 9232/99 $12.00 http://www.stockton-press.co.uk/onc hRAD17, a structural homolog of the Schizosaccharomyces pombe RAD17 cell cycle checkpoint gene, stimulates p53 accumulation Lei Li1, Carolyn A Peterson2, Gunilla Kanter-Smoler3, Ying-Fei Wei4, Louis S Ramagli2, Per Sunnerhagen3, Michael J Siciliano2 and Randy J Legerski*,2 1Department of Experimental Radiation Oncology, University of Texas, MD Anderson Cancer Center, Houston, Texas 77030, USA; and 2Department of Molecular Genetics, University of Texas, MD Anderson Cancer Center, Houston, Texas 77030, USA; 3Department of Molecular Biology, Lundberg Laboratory, Goeteborg University, PO Box 462, SE-405 30, Goeteborg, Sweden; 4Human Genome Sciences, Inc., Rockville, Maryland 20850, USA The RAD17 gene product of S. Pombe is an essential transition. Consequently, the cell cycle arrests at G1/ component of the checkpoint control pathway which S, S, and G2/M stages depending upon where in the responds to both DNA damage and disruption of cell cycle the damage is sensed, thus minimizing replication. We have identi®ed a human cDNA that proliferation of mutant cells and allowing damaged encodes a polypeptide which is structurally conserved DNA to be corrected by repair pathways and with the S. Pombe Rad17 protein. The human gene, interrupted replication to be completed (Elledge, designated hRAD17, predicts an encoded protein of 590 1996; Nurse, 1997; Paulovich et al., 1997). amino acids and a molecular weight of 69 kD. Amino DNA damage checkpoints in lower eukaryotes have acid sequence alignment revealed that hRad17 has been extensively investigated. In the budding yeast S. 28.3% and 52.5% similarity with the S. Pombe Rad17 Cerevisiae, scRAD9, scRAD17, scRAD24 and scMEC3 protein, and 21.8% identity and 45.8% similarity to the (the pre®xes here and after, h, sc, and sp refer to budding yeast cell cycle checkpoint protein, Rad 24. Homo sapiens, Saccaromyces cerevisiae, and Schizo- When introduced into the S. Pombe rad17 mutant, saccharomyces pombe, respectively) are required for hRAD17 was able to partially revert its hydroxyurea and the DNA damage-induced G1 and G2 arrest and S- ionizing radiation hypersensitivity, but not its UV phase regulation (Siede et al., 1994; Weinert et al., hypersensitivity. Permanent overexpression of the 1994; Paulovich and Hartwell, 1995; Paulovich et al., hRAD17 gene in human ®brosarcoma cells resulted in 1997); whereas, scPOL2, scRFC5, and scDBP11 are p53 activation and a signi®cant reduction of S- and G2/ required for the S-phase arrest induced by DNA M-phase cells accompanied by an accumulation of the replication-blocking agents (Araki et al., 1995; Navas G1-phase population, suggesting that hRAD17 may have et al., 1995; Sugimoto et al., 1996). Two kinases, a role in cell cycle checkpoint control. Immunostaining of scMec1/Esr1/Sad3 (Allen et al., 1994; Kato and HT-1080 cells transiently transfected with a hRAD17 Ogawa, 1994; Weinert et al., 1994; Sanchez et al., construct con®rmed the nuclear accumulation of p53, 1996) and scRad53/Spk1/Mec2/Sad1 (Stern et al., which mimics the induction caused by DNA damage. 1991; Allen et al., 1994; Weinert et al., 1994) appear Using FISH analysis, we have mapped the hRAD17 to be transducers of the DNA damage signal, resulting locus to human chromosome 5q11.2. in cell cycle arrest and transcriptional induction of repair genes (Elledge, 1996). In the ®ssion yeast S. Keywords: cell cycle checkpoint; DNA damage; p53; pombe, the `checkpoint-rad' group of genes including ®ssion yeast S. Pombe; RAD17; human homolog spRAD1, spRAD3, spRAD9, spRAD17, spRAD26, and spHUS1 is required for checkpoint arrest following both DNA lesions or replication blockage (Al- Khodairy and Carr, 1992; Al-Khodairy et al., 1994; Carr, 1995). The spChk1 and spCds1 kinases are Introduction required for survival upon DNA damage, or replication blockage with hydroxyurea (HU), respec- DNA damage checkpoints are signal transduction tively (Murakami and Okayama, 1995; Walworth and systems that link damage to DNA, or incomplete Bernards, 1996; Howard et al., 1998; Boddy et al., DNA synthesis, with the components of the cell cycle. 1998). spChk1 has been shown to act downstream of Signals originating from damaged DNA activate the `checkpoint rad' group as a signal transducer checkpoint pathways and target the mitotic apparatus (Ford et al., 1994; Walworth and Bernards, 1996; through a number of distinct mechanisms including: Furnari et al., 1997). induction of cdk inhibitors, down-regulation of cyclin In mammals, ®ve genes, ATM, p53, p21/WAF1/ expression, and inhibition of cdk phosphorylation/ CIP1, hCHK1, and 14-3-3s have been identi®ed as dephosphorylation required in normal cell cycle components of DNA damage-induced checkpoint pathways. The Atm kinase, p53, and hChk1 are signal processing and transmitting factors (Yin et al., 1992; Savitsky et al., 1995; Sanchez et al., 1997), while p21, *Correspondence: RJ Legerski and, possibly, 14-3-3s are eectors of checkpoint arrest Received 5 June 1998; revised 21 September 1998; accepted 6 October (El-Deiry et al., 1993; Harper et al., 1993; Hermeking 1998 et al., 1997). A member of the PI-3 kinase family, the Human homolog of S. pombe rad17 LLiet al 1690 ATM gene may actually function as a protein kinase Results (Hunter, 1995). It has proven to be involved in G1/S, S, and G2/M DNA damage checkpoints, and is an Identi®cation of the hRAD17 gene element upstream of p53, since cells lacking ATM show a reduced activation of p53 in response to DNA The S. pombe RAD17 gene is a structural homolog of damage (Kastan et al., 1992). Upon DNA damage, the scRAD24. Both genes appear to function at initial p53 cellular level, stability, and speci®c activity as a steps of checkpoint control, and the scRad24 protein transcription factor are up-regulated (Lu and Lane, has been implicated in damage processing (Lydall and 1993; Levine, 1997). One of the targets of p53 Weinert, 1995). Loss of spRAD17 in S. pombe transactivation is the p21/CIP1/WAF1 gene, a down- abrogates the G2 checkpoint and results in sensitivity stream eector of the G1 checkpoint. p21 binds and to DNA damage and replication blocking reagents inhibits a number of cyclin-dependent kinases, and (Griths et al., 1995). To identify a human homolog mediates the arrest at the G1/S transition. In addition, of spRad17, the full-length peptide sequence of it interacts with PCNA, thereby inhibiting DNA spRad17 was used to conduct a BLAST search of replication, and possibly eecting S phase arrest. The the human EST database at Human Geonome human Chk1 kinase is phosphorylated upon DNA Sciences, Inc. (HGS, Rockville, MD, USA). One damage, in a mechanism possibly mediated by Atm EST sequence possessed a predicted 60 amino acid (Nurse, 1997), and phosphorylates Cdc25C on Ser216, region with 29% identity and 56% similarity to resulting in a sequestration of Cdc25C phosphatase spRad17. The complete nucleotide sequence of the activity, which is necessary for the activation of Cdc2- 1.7 Kb EST insert was determined, and sequence cyclin B and mitotic entry. Thus far, signal transducing alignment analysis revealed that the amino acid factors and the downstream eectors of the damage sequence from the largest open reading frame shared checkpoint have been partially elucidated in mammals. homology with the C-terminal half of spRad17 as well However, upstream elements which are responsible for as scRad24. Therefore, a HeLa cDNA library was detecting damage and originating checkpoint signals screened, using the EST sequence as a probe, to obtain remain largely unknown. a full-length cDNA. The longest cDNA clone Structural and functional conservation of the DNA obtained, after screening 400 000 colonies, contained damage checkpoint genes have been observed among a 2.8 Kb insert. Sequence analysis indicated that this budding yeast, ®ssion yeast, and mammals (Elledge cDNA insert is 2812 bp in length, has 268 bp of 5' 1996; Paulovich et al., 1997), indicating that there is a untranslated region, an open reading frame of 2013 bp common molecular mechanism underlying checkpoint and 532 bp of 3' untranslated region. An inframe stop controls throughout eukaryotic systems. In particular, codon was found 30 bp upstream of the initiation signals derived from DNA damage are transmitted codon. The open reading frame encodes a predicted through conserved protein kinases common in all polypeptide of 671 amino acids, which shares three organisms as re¯ected by the sequence conserva- homology with both spRad17 and scRad24. When tion and functional similarity among scMec1, spRad3, aligned in a pairwise fashion, hRad17 exhibits closer Atm, and Atr. The Chk1 function and the involve- homology to spRad17, than to scRad24, with 28.3% ment of the 14-3-3 proteins were also shown to be identity and 52.7% similarity to the former protein, strictly conserved between ®ssion yeast and humans and 21.8% identity and 45.8% similarity to the latter. (Ford et al., 1994; Furnari et al., 1997; Peng et al., Both the scRad24 and spRad17 proteins are known 1997; Sanchez et al., 1997). Therefore, it is reasonable to exhibit signi®cant structural conservation with a that certain upstream components which are respon- family of proteins identi®ed as components of human sible for detecting DNA damage and producing initial RFC/activator 1, and with E. coli and bacteriophage checkpoint signals, such as scRAD9, scRAD17, T4 DNA polymerase accessory factors (O'Donnell et scRAD24 in S. Cerevisiae and spRAD1, spRAD9, al., 1993; Griths et al., 1995). The hRad17 protein and spRAD17 in S. pombe, may also exist and be also exhibits homology to these proteins (Figure 1). required in mammalian DNA damage checkpoints. In RFC is a multifactorial complex composed of ®ve fact, a human cDNA homologous to spRAD9 has subunits and functions as a loading factor for PCNA been isolated and was found partially active in during DNA polymerases d and e-mediated DNA rescuing a sprad9 mutant phenotype (Lieberman et synthesis (Pan et al., 1993).
Recommended publications
  • ATR Pathway Inhibition Is Synthetically Lethal in Cancer Cells with ERCC1 Deficiency
    Published OnlineFirst March 24, 2014; DOI: 10.1158/0008-5472.CAN-13-3229 Cancer Therapeutics, Targets, and Chemical Biology Research ATR Pathway Inhibition Is Synthetically Lethal in Cancer Cells with ERCC1 Deficiency Kareem N. Mohni, Gina M. Kavanaugh, and David Cortez Abstract The DNA damage response kinase ATR and its effector kinase CHEK1 are required for cancer cells to survive oncogene-induced replication stress. ATR inhibitors exhibit synthetic lethal interactions, with deficiencies in the DNA damage response enzymes ATM and XRCC1 and with overexpression of the cell cycle kinase cyclin E. Here, we report a systematic screen to identify synthetic lethal interactions with ATR pathway–targeted drugs, rationalized by their predicted therapeutic utility in the oncology clinic. We found that reduced function in the ATR pathway itself provided the strongest synthetic lethal interaction. In addition, we found that loss of the structure-specific endonuclease ERCC1-XPF (ERCC4) is synthetic lethal with ATR pathway inhibitors. ERCC1- deficient cells exhibited elevated levels of DNA damage, which was increased further by ATR inhibition. When treated with ATR or CHEK1 inhibitors, ERCC1-deficient cells were arrested in S-phase and failed to complete cell-cycle transit even after drug removal. Notably, triple-negative breast cancer cells and non–small cell lung cancer cells depleted of ERCC1 exhibited increased sensitivity to ATR pathway–targeted drugs. Overall, we concluded that ATR pathway–targeted drugs may offer particular utility in cancers with reduced ATR pathway function or reduced levels of ERCC4 activity. Cancer Res; 74(10); 1–11. Ó2014 AACR. Introduction repair pathway such as homologous recombination or post- – Replicating DNA is sensitive to a wide array of endogenous replicative repair to remove the PARP DNA complexes (7).
    [Show full text]
  • Supplementary Table S1. Correlation Between the Mutant P53-Interacting Partners and PTTG3P, PTTG1 and PTTG2, Based on Data from Starbase V3.0 Database
    Supplementary Table S1. Correlation between the mutant p53-interacting partners and PTTG3P, PTTG1 and PTTG2, based on data from StarBase v3.0 database. PTTG3P PTTG1 PTTG2 Gene ID Coefficient-R p-value Coefficient-R p-value Coefficient-R p-value NF-YA ENSG00000001167 −0.077 8.59e-2 −0.210 2.09e-6 −0.122 6.23e-3 NF-YB ENSG00000120837 0.176 7.12e-5 0.227 2.82e-7 0.094 3.59e-2 NF-YC ENSG00000066136 0.124 5.45e-3 0.124 5.40e-3 0.051 2.51e-1 Sp1 ENSG00000185591 −0.014 7.50e-1 −0.201 5.82e-6 −0.072 1.07e-1 Ets-1 ENSG00000134954 −0.096 3.14e-2 −0.257 4.83e-9 0.034 4.46e-1 VDR ENSG00000111424 −0.091 4.10e-2 −0.216 1.03e-6 0.014 7.48e-1 SREBP-2 ENSG00000198911 −0.064 1.53e-1 −0.147 9.27e-4 −0.073 1.01e-1 TopBP1 ENSG00000163781 0.067 1.36e-1 0.051 2.57e-1 −0.020 6.57e-1 Pin1 ENSG00000127445 0.250 1.40e-8 0.571 9.56e-45 0.187 2.52e-5 MRE11 ENSG00000020922 0.063 1.56e-1 −0.007 8.81e-1 −0.024 5.93e-1 PML ENSG00000140464 0.072 1.05e-1 0.217 9.36e-7 0.166 1.85e-4 p63 ENSG00000073282 −0.120 7.04e-3 −0.283 1.08e-10 −0.198 7.71e-6 p73 ENSG00000078900 0.104 2.03e-2 0.258 4.67e-9 0.097 3.02e-2 Supplementary Table S2.
    [Show full text]
  • The Role of the C-Terminus Merlin in Its Tumor Suppressor Function Vinay Mandati
    The role of the C-terminus Merlin in its tumor suppressor function Vinay Mandati To cite this version: Vinay Mandati. The role of the C-terminus Merlin in its tumor suppressor function. Agricultural sciences. Université Paris Sud - Paris XI, 2013. English. NNT : 2013PA112140. tel-01124131 HAL Id: tel-01124131 https://tel.archives-ouvertes.fr/tel-01124131 Submitted on 19 Mar 2015 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. 1 TABLE OF CONTENTS Abbreviations ……………………………………………………………………………...... 8 Resume …………………………………………………………………………………… 10 Abstract …………………………………………………………………………………….. 11 1. Introduction ………………………………………………………………………………12 1.1 Neurofibromatoses ……………………………………………………………………….14 1.2 NF2 disease ………………………………………………………………………………15 1.3 The NF2 gene …………………………………………………………………………….17 1.4 Mutational spectrum of NF2 gene ………………………………………………………..18 1.5 NF2 in other cancers ……………………………………………………………………...20 2. ERM proteins and Merlin ……………………………………………………………….21 2.1 ERMs ……………………………………………………………………………………..21 2.1.1 Band 4.1 Proteins and ERMs …………………………………………………………...21 2.1.2 ERMs structure ………………………………………………………………………....23 2.1.3 Sub-cellular localization and tissue distribution of ERMs ……………………………..25 2.1.4 ERM proteins and their binding partners ……………………………………………….25 2.1.5 Assimilation of ERMs into signaling pathways ………………………………………...26 2.1.5. A. ERMs and Ras signaling …………………………………………………...26 2.1.5. B. ERMs in membrane transport ………………………………………………29 2.1.6 ERM functions in metastasis …………………………………………………………...30 2.1.7 Regulation of ERM proteins activity …………………………………………………...31 2.1.7.
    [Show full text]
  • Signature of Progression and Negative Outcome in Colorectal Cancer
    Oncogene (2010) 29, 876–887 & 2010 Macmillan Publishers Limited All rights reserved 0950-9232/10 $32.00 www.nature.com/onc ORIGINAL ARTICLE A ‘DNA replication’ signature of progression and negative outcome in colorectal cancer M-J Pillaire1,7, J Selves2,7, K Gordien2, P-A Gouraud3, C Gentil3, M Danjoux2,CDo3, V Negre4, A Bieth1, R Guimbaud2, D Trouche5, P Pasero6,MMe´chali6, J-S Hoffmann1 and C Cazaux1 1Genetic Instability and Cancer Group, Department Biology of Cancer, Institute of Pharmacology and Structural Biology, UMR5089 CNRS, University of Toulouse, University Paul Sabatier, Toulouse, France; 2INSERM U563, Federation of Digestive Cancerology and Department of Anatomo-pathology, University of Toulouse, University Paul Sabatier, Toulouse, France; 3Service of Epidemiology, INSERM U558, Faculty of Medicine, University of Toulouse, University Paul Sabatier, Alle´es Jules Guesde, Toulouse, France; 4aCGH GSO Canceropole Platform, INSERM U868, Val d’Aurelle, Montpellier, France; 5Laboratory of Cellular and Molecular Biology of Cell Proliferation Control, UMR 5099 CNRS, University of Toulouse, University Paul Sabatier, Toulouse, France and 6Institute of Human Genetics UPR1142 CNRS, Montpellier, France Colorectal cancer is one of the most frequent cancers Introduction worldwide. As the tumor-node-metastasis (TNM) staging classification does not allow to predict the survival of DNA replication in normal cells is regulated by an patients in many cases, additional prognostic factors are ‘origin licensing’ mechanism that ensures that it occurs needed to better forecast their outcome. Genes involved in just once per cycle. Once cells enter the S-phase, the DNA replication may represent an underexplored source stability of DNA replication forks must be preserved to of such prognostic markers.
    [Show full text]
  • A Review of Prostate Cancer Genome-Wide Association Studies (GWAS)
    Published OnlineFirst January 18, 2018; DOI: 10.1158/1055-9965.EPI-16-1046 Review Cancer Epidemiology, Biomarkers A Review of Prostate Cancer Genome-Wide & Prevention Association Studies (GWAS) Sarah Benafif1, Zsofia Kote-Jarai1, and Rosalind A. Eeles1,2, on behalf of the PRACTICAL Consortium Abstract Prostate cancer is the most common cancer in men in for population-based risk stratification to target prostate Europe and the United States. The genetic heritability of cancer screening to men with an increased genetic risk of prostate cancer is contributed to by both rarely occurring disease development, while for those who develop prostate genetic variants with higher penetrance and moderate cancer, identifying genetic variants could allow treatment to commonly occurring variants conferring lower risks. to be tailored based on a genetic profile in the early disease The number of identified variants belonging to the latter setting. Functional studies of identified variants are needed category has increased dramatically in the last 10 years with to fully understand underlying mechanisms of disease the development of the genome-wide association study and identify novel targets for treatment. This review will (GWAS) and the collaboration of international consortia outline the GWAS carried out in prostate cancer and the that have led to the sharing of large-scale genotyping data. common variants identified so far, and how these may be Over 40 prostate cancer GWAS have been reported, with utilized clinically in the screening for and management of approximately 170 common variants now identified. prostate cancer. Cancer Epidemiol Biomarkers Prev; 27(8); 845–57. Clinical utility of these variants could include strategies Ó2018 AACR.
    [Show full text]
  • Exploring Extracellular Vesicles Biogenesis in Hypothalamic Cells Through a Heavy Isotope Pulse/Trace Proteomic Approach
    cells Article Exploring Extracellular Vesicles Biogenesis in Hypothalamic Cells through a Heavy Isotope Pulse/Trace Proteomic Approach Chee Fan Tan 1,2 , Hui San Teo 2, Jung Eun Park 2, Bamaprasad Dutta 2, Shun Wilford Tse 2, Melvin Khee-Shing Leow 3,4,5 , Walter Wahli 3,6 and Siu Kwan Sze 2,* 1 NTU Institute for Health Technologies, Interdisciplinary Graduate School, Nanyang Technological University, Singapore 637335, Singapore; [email protected] 2 School of Biological Sciences, Nanyang Technological University, Singapore 637551, Singapore; [email protected] (H.S.T.); [email protected] (J.E.P.); [email protected] (B.D.); [email protected] (S.W.T.) 3 Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore 636921, Singapore; [email protected] (M.K.-S.L.); [email protected] (W.W.) 4 Department of Endocrinology, Tan Tock Seng Hospital, Singapore 308433, Singapore 5 Cardiovascular and Metabolic Disorder Program, Duke-NUS Medical School, Singapore 169857, Singapore 6 Center for Integrative Genomics, University of Lausanne, Le Génopode, CH-1015 Lausanne, Switzerland * Correspondence: [email protected]; Tel.: +65-6514-1006; Fax: +65-6791-3856 Received: 24 March 2020; Accepted: 21 May 2020; Published: 25 May 2020 Abstract: Studies have shown that the process of extracellular vesicles (EVs) secretion and lysosome status are linked. When the lysosome is under stress, the cells would secrete more EVs to maintain cellular homeostasis. However, the process that governs lysosomal activity and EVs secretion remains poorly defined and we postulated that certain proteins essential for EVs biogenesis are constantly synthesized and preferentially sorted to the EVs rather than the lysosome.
    [Show full text]
  • Hypoxia Transcriptomic Modifications Induced by Proton Irradiation In
    Journal of Personalized Medicine Article Hypoxia Transcriptomic Modifications Induced by Proton Irradiation in U87 Glioblastoma Multiforme Cell Line Valentina Bravatà 1,2,† , Walter Tinganelli 3,†, Francesco P. Cammarata 1,2,* , Luigi Minafra 1,2,* , Marco Calvaruso 1,2 , Olga Sokol 3 , Giada Petringa 2, Giuseppe A.P. Cirrone 2, Emanuele Scifoni 4 , Giusi I. Forte 1,2,‡ and Giorgio Russo 1,2,‡ 1 Institute of Molecular Bioimaging and Physiology–National Research Council (IBFM-CNR), 90015 Cefalù, Italy; [email protected] (V.B.); [email protected] (M.C.); [email protected] (G.I.F.); [email protected] (G.R.) 2 Laboratori Nazionali del SUD, Istituto Nazionale di Fisica Nucleare (LNS-INFN), 95100 Catania, Italy; [email protected] (G.P.); [email protected] (G.A.P.C.) 3 Biophysics Department, GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany; [email protected] (W.T.); [email protected] (O.S.) 4 Trento Institute for Fundamental Physics and Applications (TIFPA), Istituto Nazionale Fisica Nucleare (INFN), 38123 Trento, Italy; [email protected] * Correspondence: [email protected] (F.P.C.); [email protected] (L.M.) † These authors contributed equally to this work. ‡ These authors contributed equally to this work. Abstract: In Glioblastoma Multiforme (GBM), hypoxia is associated with radioresistance and poor prognosis. Since standard GBM treatments are not always effective, new strategies are needed Citation: Bravatà, V.; Tinganelli, W.; to overcome resistance to therapeutic treatments, including radiotherapy (RT). Our study aims Cammarata, F.P.; Minafra, L.; to shed light on the biomarker network involved in a hypoxic (0.2% oxygen) GBM cell line that Calvaruso, M.; Sokol, O.; Petringa, G.; is radioresistant after proton therapy (PT).
    [Show full text]
  • DNA Distress: Just Ring 9-1-1 [9,11]
    CORE Metadata, citation and similar papers at core.ac.uk Provided by Elsevier - Publisher Connector Dispatch R733 DNA Distress: Just Ring 9-1-1 [9,11]. Interestingly, the Rad9 carboxyl terminus plays an important role in activation of the DNA damage The Rad9–Hus1–Rad1 checkpoint clamp (9-1-1) is a central player in the cellular checkpoint, which halts cell cycle response to DNA damage; three groups have determined the crystal structure progression to provide time for of 9-1-1, providing new insight into its loading mechanism and association with DNA repair [1]. Phosphorylation of DNA damage checkpoint and repair enzymes. this domain is required for binding and recruiting TopBP1 to sites of Michael Kemp and Aziz Sancar PCNA and 9-1-1 require the DNA damage [17] in order to activity of heteropentameric clamp activate the DNA damage response The genome is constantly exposed to loading complexes termed replication kinase ATR [18]. Unfortunately, to cellular metabolites and exogenous factor C (RFC) and Rad17-RFC, obtain recombinant 9-1-1 protein agents that induce lesions in DNA respectively, which bind to, open, suitable for crystallization, all capable of causing mutation, cancer, and clamp the complexes around three groups [9–11] used a truncated or cell death. In response to such DNA [13]. Whereas PCNA is loaded form of Rad9 lacking this region, damage, eukaryotic cells activate onto 30-primer–template junctions and hence the structures provide signaling pathways that promote DNA by the canonical RFC made up of no insight into the role of the Rad9 repair, allow bypass of lesions during RFC1–5, 9-1-1 is instead preferentially carboxyl terminus in the checkpoint DNA replication, and halt cell-cycle loaded onto 50-recessed ends by response.
    [Show full text]
  • Hunter Et Al CLSPN
    bioRxiv preprint doi: https://doi.org/10.1101/358291; this version posted June 28, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Regulation of checkpoint kinase signalling and tumorigenesis by the NF-κB regulated gene, CLSPN Jill E. Hunter1, Jacqueline A. Butterworth1, Helene Sellier1, Saimir Luli2, Achilleas Floudas2, Adam J. Moore1, Huw D. Thomas3, Kirsteen J. Campbell4, Niall S. Kenneth1, Robson T. Chiremba1, Dina Tiniakos2, Andrew M. Knight2, Benjamin E. Gewurz5, Fiona Oakley2, Michelle D. Garrett6,7, Ian Collins7, and Neil D. Perkins1* 1Institute for Cell and Molecular Biosciences 2Institute of Cellular Medicine 3Northern Institute for Cancer Research Faculty of Medical Sciences Newcastle University Newcastle Upon Tyne, NE2 4HH, UK 4The Beatson Institute for Cancer Research Glasgow, G61 1BD, UK 5Brigham and Women's Hospital, Boston, MA 02115, USA 6School of Biosciences, University of Kent Canterbury, CT2 7NJ, UK 7The Institute of Cancer Research Sutton, SM2 5NG, UK * corresponding author Tel. 0191 2088866 Fax. 0191 2087424 Email: [email protected] Running Title: NF-κB regulation of CHK1 inhibitor sensitivity Word count: 1 bioRxiv preprint doi: https://doi.org/10.1101/358291; this version posted June 28, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract Inhibition of the tumour promoting activities of NF-κB by cell signalling pathways has been proposed as a natural mechanism to limit the development of cancer. However, there has been a lack of evidence for these effects in vivo.
    [Show full text]
  • Cdna Cloning and Gene Mapping of Human Homologs For
    GENOMICS 54, 424–436 (1998) ARTICLE NO. GE985587 cDNA Cloning and Gene Mapping of Human Homologs for Schizosaccharomyces pombe rad17, rad1, and hus1 and Cloning of Homologs from Mouse, Caenorhabditis elegans, and Drosophila melanogaster Frank B. Dean,*,1 Lubing Lian,† and Mike O’Donnell*,‡ *The Rockefeller University and ‡The Howard Hughes Medical Institute, 1230 York Avenue, New York, New York 10021; and †Myriad Genetics, Inc., 390 Wakara Way, Salt Lake City, Utah 84108 Received July 13, 1998; accepted September 17, 1998 INTRODUCTION Mutations in DNA repair/cell cycle checkpoint genes can lead to the development of cancer. The cloning of The progression of a eukaryotic cell through the human homologs of yeast DNA repair/cell cycle check- stages of the cell cycle can be arrested if the events of point genes should yield candidates for human tumor the previous stage of the cell cycle, such as DNA rep- suppressor genes as well as identifying potential tar- lication, have not been completed or if the DNA has gets for cancer therapy. The Schizosaccharomyces sustained some type of damage. The controls on cell pombe genes rad17, rad1, and hus1 have been identi- cycle progression are termed checkpoints (Hartwell fied as playing roles in DNA repair and cell cycle and Weinert, 1989), and they are able to detect checkpoint control pathways. We have cloned the whether the processes of the individual stages of the cDNA for the human homolog of S. pombe rad17, cell cycle have been completed and whether the DNA is RAD17, which localizes to chromosomal location 5q13 intact or in need of repair.
    [Show full text]
  • Somatic Mutation of the Cohesin Complex Subunit Confers Therapeutic Vulnerabilities in Cancer
    Somatic mutation of the cohesin complex subunit confers therapeutic vulnerabilities in cancer Yunhua Liu, … , Guang Ji, Xiongbin Lu J Clin Invest. 2018;128(7):2951-2965. https://doi.org/10.1172/JCI98727. Research Article Oncology Therapeutics A synthetic lethality–based strategy has been developed to identify therapeutic targets in cancer harboring tumor- suppressor gene mutations, as exemplified by the effectiveness of poly ADP-ribose polymerase (PARP) inhibitors in BRCA1/2-mutated tumors. However, many synthetic lethal interactors are less reliable due to the fact that such genes usually do not perform fundamental or indispensable functions in the cell. Here, we developed an approach to identifying the “essential lethality” arising from these mutated/deleted essential genes, which are largely tolerated in cancer cells due to genetic redundancy. We uncovered the cohesion subunit SA1 as a putative synthetic-essential target in cancers carrying inactivating mutations of its paralog, SA2. In SA2-deficient Ewing sarcoma and bladder cancer, further depletion of SA1 profoundly and specifically suppressed cancer cell proliferation, survival, and tumorigenic potential. Mechanistically, inhibition of SA1 in the SA2-mutated cells led to premature chromatid separation, dramatic extension of mitotic duration, and consequently, lethal failure of cell division. More importantly, depletion of SA1 rendered those SA2- mutated cells more susceptible to DNA damage, especially double-strand breaks (DSBs), due to reduced functionality of DNA repair. Furthermore,
    [Show full text]
  • T-, B-And NK-Lymphoid, but Not Myeloid Cells Arise from Human
    Leukemia (2007) 21, 311–319 & 2007 Nature Publishing Group All rights reserved 0887-6924/07 $30.00 www.nature.com/leu ORIGINAL ARTICLE T-, B- and NK-lymphoid, but not myeloid cells arise from human CD34 þ CD38ÀCD7 þ common lymphoid progenitors expressing lymphoid-specific genes I Hoebeke1,3, M De Smedt1, F Stolz1,4, K Pike-Overzet2, FJT Staal2, J Plum1 and G Leclercq1 1Department of Clinical Chemistry, Microbiology and Immunology, Ghent University Hospital, Ghent, Belgium and 2Department of Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands Hematopoietic stem cells in the bone marrow (BM) give rise to share a direct common progenitor either, as CLPs were not all blood cells. According to the classic model of hematopoi- found in the fetal liver.5 Instead, fetal B and T cells would esis, the differentiation paths leading to the myeloid and develop through B/myeloid and T/myeloid intermediates. lymphoid lineages segregate early. A candidate ‘common 6 lymphoid progenitor’ (CLP) has been isolated from The first report of a human CLP came from Galy et al. who À þ CD34 þ CD38À human cord blood cells based on CD7 expres- showed that a subpopulation of adult and fetal BM Lin CD34 sion. Here, we confirm the B- and NK-differentiation potential of cells expressing the early B- and T-cell marker CD10 is not þ À þ CD34 CD38 CD7 cells and show in addition that this capable of generating monocytic, granulocytic, erythroid or population has strong capacity to differentiate into T cells. As megakaryocytic cells, but can differentiate into dendritic cells, CD34 þ CD38ÀCD7 þ cells are virtually devoid of myeloid B, T and NK cells.
    [Show full text]